Search research articles
Contact Us
Filters
Showing results (1-10 of 134) with videos related to
Page
of 14
Sort By:
European Journal of Internal Medicine
|
June 26, 2012
The role of lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia
Angelika Reissig, Andrea Gramegna, Stefano Aliberti
Expert Opinion on Pharmacotherapy
|
February 5, 2021
Mycoplasma pneumoniae: a pathogen with unsolved therapeutic problems
Susanna Esposito, Alberto Argentiero, Andrea Gramegna, et al.
Current Opinion in Pharmacology
|
February 14, 2021
Elexacaftor-tezacaftor-ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation
Andrea Gramegna, Martina Contarini, Francesco Bindo, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 29, 2020
New Antibiotics for the Treatment of Acute Bacterial Skin and Soft Tissue Infections in Pediatrics
Nicola Principi, Alberto Argentiero, Cosimo Neglia, et al.
Expert Opinion on Pharmacotherapy
|
August 19, 2020
Pharmacotherapeutic management of bronchial infections in adults: non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease
Marta Di Pasquale, Stefano Aliberti, Marco Mantero, et al.
Archives of Gynecology and Obstetrics
|
July 30, 2023
Unplanned pregnancies following the introduction of elexacaftor/tezacaftor/ivacaftor therapy in women with cystic fibrosis
Valeria Daccò, Gianfranco Alicandro, Laura Trespidi, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 11, 2026
Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research
Andrea Gramegna, Gianmarco Putti, Gianfranco Alicandro, et al.
Respiration; International Review of Thoracic Diseases
|
January 23, 2017
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For
Francesco Amati, Elisa Franceschi, Andrea Gramegna, et al.
International Journal of Molecular Sciences
|
August 23, 2020
From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
Andrea Gramegna, Martina Contarini, Stefano Aliberti, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
January 16, 2013
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis
Stefano Aliberti, Grazia Messinesi, Andrea Gramegna, et al.
Page
of 14
Search research articles
Search
Showing results (1-10 of 134) with videos related to
Sort By:
Page
of 14
European Journal of Internal Medicine
|
June 26, 2012
The role of lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia
Angelika Reissig, Andrea Gramegna, Stefano Aliberti
Expert Opinion on Pharmacotherapy
|
February 5, 2021
Mycoplasma pneumoniae: a pathogen with unsolved therapeutic problems
Susanna Esposito, Alberto Argentiero, Andrea Gramegna, et al.
Current Opinion in Pharmacology
|
February 14, 2021
Elexacaftor-tezacaftor-ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation
Andrea Gramegna, Martina Contarini, Francesco Bindo, et al.
Pharmaceuticals (Basel, Switzerland)
|
October 29, 2020
New Antibiotics for the Treatment of Acute Bacterial Skin and Soft Tissue Infections in Pediatrics
Nicola Principi, Alberto Argentiero, Cosimo Neglia, et al.
Expert Opinion on Pharmacotherapy
|
August 19, 2020
Pharmacotherapeutic management of bronchial infections in adults: non-cystic fibrosis bronchiectasis and chronic obstructive pulmonary disease
Marta Di Pasquale, Stefano Aliberti, Marco Mantero, et al.
Archives of Gynecology and Obstetrics
|
July 30, 2023
Unplanned pregnancies following the introduction of elexacaftor/tezacaftor/ivacaftor therapy in women with cystic fibrosis
Valeria Daccò, Gianfranco Alicandro, Laura Trespidi, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 11, 2026
Residual disease activity in cystic fibrosis lung disease: implications for clinical management and research
Andrea Gramegna, Gianmarco Putti, Gianfranco Alicandro, et al.
Respiration; International Review of Thoracic Diseases
|
January 23, 2017
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For
Francesco Amati, Elisa Franceschi, Andrea Gramegna, et al.
International Journal of Molecular Sciences
|
August 23, 2020
From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
Andrea Gramegna, Martina Contarini, Stefano Aliberti, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
January 16, 2013
Diaphragm ultrasonography in the management of patients with amyotrophic lateral sclerosis
Stefano Aliberti, Grazia Messinesi, Andrea Gramegna, et al.
Page
of 14